Should Bone Turnover Markers Be Used Routinely to Monitor Oral Bisphosphonate Osteoporosis Therapy? No: Measurement Is Unnecessary and a Poor Use of Medical Resources

Authors

Herbert L. Muncie, LSU Health Sciences Center - New OrleansFollow
David J. Mohr, LSU Health Sciences Center - New OrleansFollow
Madeleine L. Maras, LSU Health Sciences Center - New OrleansFollow

Document Type

Editorial

Publication Date

11-1-2023

Publication Title

American Family Physician

First Page

444

Last Page

446

PubMed ID

37983692

Volume

108

Issue

5

Recommended Citation

Muncie, Herbert L.; Mohr, David J.; and Maras, Madeleine L., "Should Bone Turnover Markers Be Used Routinely to Monitor Oral Bisphosphonate Osteoporosis Therapy? No: Measurement Is Unnecessary and a Poor Use of Medical Resources" (2023). School of Medicine Faculty Publications. 1881.
https://digitalscholar.lsuhsc.edu/som_facpubs/1881